Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

BACKGROUND: We evaluated preoperative CA 19-9 levels in patients with resected pancreatic cancer to analyze whether they were predictive of clinical outcomes and could help select patients for additional therapy. We hypothesized that elevated CA 19-9 would be associated with worse pathologic finding...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Oncol
Hoofdauteurs: Kowalchuk, Roman O., Lester, Scott C., Graham, Rondell P., Harmsen, William S., Zhang, Lizhi, Halfdanarson, Thorvardur R., Smoot, Rory L., Gits, Hunter C., Ma, Wen Wee, Owen, Dawn, Mahipal, Amit, Miller, Robert C., Wittich, Michelle A. Neben, Cleary, Sean P., McWilliams, Robert R., Haddock, Michael G., Hallemeier, Christopher L., Truty, Mark J., Merrell, Kenneth W.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2021
Onderwerpen:
Oncology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8147692/
https://ncbi.nlm.nih.gov/pubmed/34046346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.651119
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items